Glenmark Life Sciences Limited
ListedMainboardHealthcare & Pharmaceuticals · NSE / BSE
Incorporated in 2011, Glenmark Life Sciences is a leading manufacturer of active pharmaceutical ingredients (APIs), developing and supplying high-quality products used in treatments for cardiovascular, central nervous system, pain management, diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas. The company serves customers in India and exports its products to several international markets including Europe, North America, Latin America, and Japan. It operates four manufacturing facilities located at Ankleshwar and Dahej in Gujarat, and Mohol and Kurkumbh in Maharashtra, with a total annual installed capacity of 725.8 KL as of December 31, 2020.
Price Band
₹695 – ₹720
Issue Size
₹1514 Cr
Lot Size
20 shares
GMP
₹82
+11.4%
Est. Listing
₹802
at current GMP
Subscribed
—
Open
27 Jul 2021
Close
29 Jul 2021
Allotment
3 Aug 2021
Refund
4 Aug 2021
Demat Credit
5 Aug 2021
Listing
6 Aug 2021
Last updated 12 days ago
Live Grey Market Premium
Glenmark Life Sciences Limited GMP Today
Last updated: 19 Oct 2026
Current Premium
₹82+11.4%
Issue Price (Upper)
₹720
Band: ₹695 – ₹720
Estimated Listing Price
₹802
Upper price + GMP
Lot Size
20 shares
Min investment ₹14,400
Estimated Profit / Lot
₹1,640
20 × ₹82
Glenmark Life Sciences Limited GMP Historical Trend
GMP History
Grey Market Premium trend
+₹82
▲ 0 today
Updated 1 minute ago
Estimated Listing Price
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹82 | 11.4% | ₹802 |
| 30 Oct 2026 | +₹82 | 11.4% | ₹802 |
| 29 Oct 2026 | +₹74 | 10.3% | ₹794 |
GMP is unofficial market data. Not a guarantee of listing performance.
About Glenmark Life Sciences Limited Public Issue & Market Profile
Glenmark Life Sciences Limited is bringing an initial public offering (IPO) in the Healthcare & Pharmaceuticals sector with an aggregate issue size of ₹1,514 Crores. The shares are offered at a price band of ₹695 to ₹720 per equity share on NSE and BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Public Issue & Pricing Context:
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 20 shares (approx. ₹14,400 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Basis of Allotment & Listing Timeline:
Allotment reconciliation will be managed by Kfin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2021-08-05, while un-allotted funds or UPI block mandates will be released on 2021-08-04.
Frequently Asked Questions
What is Glenmark Life Sciences Limited IPO GMP today?
The latest grey market premium for Glenmark Life Sciences Limited IPO is ₹82, which indicates an expected listing price of ₹802.
What does Kostak Rate and Sauda mean in IPO GMP?
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
Is Grey Market Premium officially recognized?
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.